Furoxan derivatives demonstrated in vivo efficacy by reducing Mycobacterium tuberculosis to undetectable levels in a mouse model of infection

Publication date: October 2020Source: Biomedicine & Pharmacotherapy, Volume 130Author(s): P.C. de Souza, G.F.S. Fernandes, L.B. Marino, C.M. Ribeiro, P.B. da Silva, M. Chorilli, C.S.P. Silva, F.A. Resende, M.C. Solcia, R.A. de Grandis, C.A.S. Costa, S.H. Cho, Y. Wang, S.G. Franzblau, J.L. dos Santos, F.R. Pavan
Source: Biomedicine and Pharmacotherapy - Category: Drugs & Pharmacology Source Type: research